{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:45:56Z","timestamp":1773063956804,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijpharm.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T15:22:18Z","timestamp":1459869738000},"page":"212-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro \/ in-vivo evaluation"],"prefix":"10.1016","volume":"505","author":[{"given":"Shahinaze A.","family":"Fouad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab N.","family":"Shamma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad B.","family":"Basalious","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"El-Nabarawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadia A.","family":"Tayel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.04.006_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijpharm.2015.05.064","article-title":"Investigating the cubosomal ability for transnasal brain targeting: In-vitro optimization, ex vivo permeation and in-vivo biodistribution","volume":"490","author":"Abdelrahman","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3109\/10837450.2011.619543","article-title":"Development and optimization of lyophilized orally disintegrating tablets using factorial design","volume":"18","author":"Ahmed","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2014.06.041","article-title":"Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment","volume":"472","author":"Al-Mahallawi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1464-410X.2006.05911.x","article-title":"Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for \u2018on-demand' treatment of premature ejaculation","volume":"97","author":"Andersson","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1208\/s12249-011-9646-6","article-title":"Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets","volume":"12","author":"Basalious","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12247-014-9196-z","article-title":"Utility of mannitol and citric acid for enhancing the solubilizing and taste masking properties of \u03b2-cyclodextrin: development of fast-dissolving tablets containing extremely bitter drug","volume":"9","author":"Basalious","year":"2014","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gerinurse.2008.04.007","article-title":"Use of selective serotonin reuptake inhibitors in the treatment of depression in older adults: identifying and managing potential risk for hyponatremia","volume":"30","author":"Bowen","year":"2009","journal-title":"Geriatr. Nurs."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2008.11.011","article-title":"The role of formulation excipients in the development of lyophilised fast-disintegrating tablets","volume":"72","author":"Chandrasekhar","year":"2009","journal-title":"Eur. J. Pharm. Biopharm.V"},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.002","article-title":"Comparative study of Pluronic((R)) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats","volume":"449","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/20014091091904","article-title":"Gelatin: a valuable protein for food and pharmaceutical industries: review","volume":"41","author":"Djagny","year":"2001","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In-vitro and in-vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2004.07.033","article-title":"Formulation and evaluation of diclofenac sodium buccoadhesive discs","volume":"286","author":"El-Samaligy","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejps.2015.04.015","article-title":"Preclinical evaluation of dual action intranasal formulation intended for postoperative\/cancer associated therapies","volume":"76","author":"El-Setouhy","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2015.06.006","article-title":"Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: in-vitro\/in-vivo evaluation","volume":"94","author":"El-Setouhy","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0080","first-page":"339","article-title":"Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations","volume":"9","author":"Escobar-Chavez","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0085","unstructured":"European Pharmacopoeia, f.e., Suppl. 4.1., 2002. fourth ed. ed. published by the directorate for the quality of medicines of the council of Europe, Strasbourg, France."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2005.07.001","article-title":"Study of formulation variables influencing the drug release rate from matrix tablets by experimental design","volume":"62","author":"Furlanetto","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0095","first-page":"37","article-title":"Emerging treatments for premature ejaculation: focus on dapoxetine","volume":"5","author":"Hellstrom","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejps.2010.02.002","article-title":"Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride","volume":"40","author":"Huh","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0105","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jps.2600691037","article-title":"Nasal absorption of propranolol in humans","volume":"69","author":"Hussain","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0110","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1021\/mp500825n","article-title":"Formulation of convenient, easily scalable, and efficient granisetron HCl intranasal droppable gels","volume":"12","author":"Ibrahim","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.2002.01588.x","article-title":"Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray: a study in healthy volunteers","volume":"53","author":"Knoester","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2005.01.018","article-title":"Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols","volume":"105","author":"Kuno","year":"2005","journal-title":"J. Control Release"},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0125","first-page":"3151","article-title":"Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in-vitro characterization, and enhanced cellular uptake","volume":"6","author":"Li","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0130","first-page":"1","article-title":"Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet","author":"Liew","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CE.S13841","article-title":"Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation","volume":"7","author":"McCarty","year":"2012","journal-title":"Core Evid."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1756287212453866","article-title":"Dapoxetine: a new option in the medical management of premature ejaculation","volume":"4","author":"McMahon","year":"2012","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1756287211424172","article-title":"Medical therapy for premature ejaculation","volume":"3","author":"Mohee","year":"2011","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0150","first-page":"1","article-title":"In-vitro pharmaceutical characterization and statistical optimization of a novel topically applied instantly-soluble solid eye drop matrix","author":"Moosa","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijpharm.2010.05.041","article-title":"Preparation and evaluation of fexofenadine microemulsions for intranasal delivery","volume":"395","author":"Piao","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.10.005","article-title":"Pluronic gels for nasal delivery of Vitamin B12: Part I: preformulation study","volume":"270","author":"Pisal","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2230-973X.96921","article-title":"Improvement in solubility of poor water-soluble drugs by solid dispersion","volume":"2","author":"Sareen","year":"2012","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0928-0987(02)00011-8","article-title":"Fast dispersible ibuprofen tablets","volume":"15","author":"Schiermeier","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpb.2009.04.005","article-title":"In-vitro and in-vivo evaluation of nimesulide lyophilized orally disintegrating tablets","volume":"73","author":"Shoukri","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1248\/cpb.50.193","article-title":"Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone","volume":"50","author":"Shu","year":"2002","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejpb.2011.02.005","article-title":"Orally disintegrating mini-tablets (ODMTs)\u2013a novel solid oral dosage form for paediatric use","volume":"78","author":"Stoltenberg","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1743-6109.2005.20112.x","article-title":"On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions","volume":"2","author":"Waldinger","year":"2005","journal-title":"J. Sex Med."},{"key":"10.1016\/j.ijpharm.2016.04.006_bib0200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","article-title":"Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties","volume":"32","author":"Zaki","year":"2007","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T17:53:26Z","timestamp":1536861206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316302812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0378517316302812"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.04.006","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro\/in-vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}